Sign In
Life Sciences Translation Services

Informed Consent Form (ICF) Translation Services for Clinical Trials

Translate informed consent forms accurately with professional native medical linguists, structured review workflows, and compliance-focused quality checks. Support patient comprehension, IRB submissions, and multilingual communication.

REQUEST A QUOTE → SPEAK WITH AN EXPERT →

Professional native medical linguists

Structured review and QA workflows

Patient-facing content expertise

Support for IRB and multi-country studies

ICF Translation Workflow

Built for regulated research

01

Source Review

Assess content, terminology, and patient-facing clarity requirements.

02

Medical Translation

Translation by native medical linguists focused on comprehension.

03

Review and QA

Independent review, terminology validation, and consistency control.

04

Delivery for Use

Ready for ethics review, IRB submission, and patient use.

Regulatory
Compliant
Quality
Focused
Global
Coverage

What Is an Informed Consent Form (ICF) in Clinical Trials?

An informed consent form (ICF) is a critical document used in clinical trials to provide participants with clear, detailed information about a study before they agree to take part. It explains the purpose of the research, study procedures, potential risks and benefits, and the rights of participants in a language they can understand.

In global clinical research, informed consent forms must be translated accurately for each target population. This is where ICF translation and informed consent translation play an important role in supporting patient comprehension and ethical study conduct across multiple countries.

ICFs are central to ethical clinical trial execution. Before enrollment, participants must review and sign the consent form to confirm they understand the study and voluntarily agree to participate.

Clinical trial consent forms typically include:

  • Study objectives and procedures
  • Potential risks and benefits
  • Participant rights, including the right to withdraw
  • Confidentiality and data protection information
  • Contact details for study-related questions

Accurate informed consent translation helps ensure that participants in every region receive the same information, regardless of language, supporting consistency across global trials.

Patient comprehension is a key requirement in clinical trials. If participants do not fully understand the information presented in the ICF, the validity of the consent process can be compromised.

High-quality ICF translation ensures that:

  • Medical terminology is clearly explained in the target language
  • Content is culturally appropriate and easy to understand
  • Patients can make informed decisions about participation

This is especially important for patient-facing documents, where clarity and readability directly impact study integrity.

Regulatory authorities and ethics committees, including Institutional Review Boards (IRBs), require that informed consent forms be translated into the local language of each study population.

These requirements are designed to protect patient rights and ensure that all participants have equal access to critical study information. In many cases, translated clinical trial consent forms must meet strict standards for accuracy, consistency, and documentation.

Professional ICF translation services support compliance by providing structured workflows, independent review, and quality checks aligned with regulatory expectations for global clinical research.

Why Accurate ICF Translation Is Critical for Global Trials

Accurate ICF translation is essential for conducting clinical trials across multiple countries. Informed consent forms are patient-facing documents that directly impact participant understanding, regulatory approval, and overall study execution. Poorly translated clinical trial consent forms can lead to confusion, compliance issues, and delays, making high-quality informed consent translation a key requirement for global research programs.

Informed consent forms must be clear, accurate, and easy to understand for participants from different linguistic and cultural backgrounds. ICF translation is not just about converting words from one language to another. It involves adapting medical and procedural information so patients can fully understand what participation involves.

Clear informed consent translation helps ensure that:

  • Patients understand study procedures, risks, and benefits
  • Medical terminology is conveyed in plain, accessible language
  • Cultural nuances do not affect meaning or interpretation

Strong patient comprehension supports ethical clinical trial conduct and allows participants to make informed decisions with confidence.

Regulatory authorities and ethics committees, including Institutional Review Boards (IRBs), require that clinical trial consent forms be translated accurately into the local language of each study population. These requirements are in place to protect patient rights and ensure transparency in the consent process.

ICF translation must meet strict expectations for:

  • Accuracy and completeness of content
  • Consistency with the original source document
  • Proper documentation for submission and review

In many cases, regulators and ethics committees will review translated informed consent forms as part of the approval process. High-quality informed consent translation helps support smoother submissions and reduces the likelihood of revision requests.

Global clinical trials often involve multiple languages and regions, making consistency across all versions of the ICF critical. Each translated document must reflect the same meaning, structure, and intent as the original while remaining clear to local participants.

Professional ICF translation supports consistency by:

  • Applying standardized terminology across all languages
  • Maintaining alignment with study protocols and amendments
  • Using structured review workflows to ensure uniform quality

Consistent clinical trial consent forms help sponsors and CROs manage global studies more effectively and maintain control across all sites.

Inaccurate or unclear ICF translation can introduce significant risks to clinical trials. Misinterpretation of study details may lead to patient confusion, protocol deviations, or regulatory concerns.

Effective informed consent translation helps reduce risk by:

  • Preventing misunderstandings in patient-facing content
  • Minimizing back-and-forth during regulatory and ethics review
  • Reducing delays caused by revisions or re-submissions
  • Supporting smoother trial execution across regions

By investing in accurate ICF translation, sponsors and CROs can protect study timelines, maintain compliance, and support reliable outcomes in global clinical research.

Our Informed Consent Form (ICF) Translation Process

Our ICF translation process is designed to support accuracy, consistency, and compliance for global clinical research. Each step is structured to ensure that informed consent forms are translated clearly for patients while maintaining alignment with regulatory expectations and study requirements.

Every project begins with a detailed review of the informed consent form and related materials. This includes evaluating study terminology, document structure, revision history, and target languages.

During this stage, we also prepare terminology resources, including glossaries and reference materials, to support consistent informed consent translation across all languages and study sites.

ICF translation is performed by professional native medical linguists with experience in clinical trial and patient-facing content. These linguists are familiar with medical terminology as well as the need to present complex information in clear, understandable language.

This ensures that clinical trial consent forms are not only accurate, but also accessible to participants from different linguistic and cultural backgrounds.

Following initial translation, each informed consent form undergoes independent linguistic review. A second qualified linguist reviews the content for accuracy, clarity, and completeness.

This structured review workflow helps identify any inconsistencies or ambiguities and ensures that the translated ICF reflects the intent of the original document while remaining clear for patient use.

Terminology management plays a key role in ICF translation, especially for multi-language clinical trials. We apply standardized terminology across all documents to maintain consistency with study protocols and previously approved materials.

Automated and manual checks are used to verify:

  • Consistent use of key medical and study terms
  • Alignment across language versions
  • Accuracy in repeated content and structured sections

This step helps maintain uniformity across all clinical trial consent forms in global studies.

Before delivery, all translated informed consent forms go through a final quality assurance review. This includes formatting checks, completeness verification, and overall consistency validation.

Where required, we can also provide a certificate of translation to support regulatory or institutional submission requirements.

Final deliverables are prepared for immediate use in clinical trials, including submission to IRBs, ethics committees, and local regulatory authorities.

Linguistic Validation for Informed Consent Forms

Linguistic validation is often required for informed consent forms (ICFs) used in global clinical trials to confirm that translated content is accurate, culturally appropriate, and clearly understood by patients in each target market. While standard ICF translation focuses on accuracy and consistency, linguistic validation goes further by verifying that patient-facing content performs as intended in real-world settings.

This process is especially important for studies involving diverse patient populations, sensitive medical conditions, or regulatory environments with strict requirements for patient comprehension.

Linguistic validation is typically required when informed consent forms are used in:

  • Multi-country clinical trials with diverse patient populations
  • Studies where patient understanding directly impacts safety and outcomes
  • Regulatory environments that require documented evidence of comprehension
  • Situations where ICF content includes complex medical or procedural language

Sponsors and CROs may request linguistic validation to strengthen regulatory submissions and demonstrate that clinical trial consent forms are appropriate for local use.

Cognitive debriefing is a key component of linguistic validation. It involves testing the translated informed consent form with representative participants from the target population to assess how well the content is understood.

During cognitive debriefing, participants are asked to review sections of the ICF and explain their understanding of key concepts. This helps identify:

  • Misinterpretations or unclear wording
  • Cultural or linguistic issues affecting comprehension
  • Opportunities to improve clarity and readability

Feedback from this process is used to refine the translation, ensuring that the final informed consent translation is both accurate and patient-friendly.

Back translation is another important step in linguistic validation. In this process, the translated ICF is translated back into the source language by an independent linguist who has not seen the original document.

The back-translated version is then compared with the original to identify any differences in meaning, omissions, or inconsistencies. This step helps verify that the translated content accurately reflects the intent of the source document.

Back translation is often used as part of regulatory submissions to provide additional assurance of translation quality.

Linguistic validation generates detailed documentation that supports regulatory and ethics review processes. This documentation may include:

  • Cognitive debriefing reports
  • Back translation comparisons
  • Revision history and justification for changes
  • Final validated versions of the informed consent form

These materials provide evidence that the ICF translation has been thoroughly evaluated and is suitable for use in clinical trials.

By incorporating linguistic validation into the translation process, sponsors and CROs can strengthen compliance, improve patient understanding, and support successful global study execution.

Clinical Trial Documents We Translate Alongside ICFs

Informed consent forms are one part of a broader set of clinical trial documentation that must be translated accurately and consistently across all study materials. To support global trial execution, we provide translation services for a full range of clinical documents, helping sponsors and CROs maintain alignment across patient-facing, regulatory, and operational content.

Translating these materials together with ICFs improves consistency in terminology, reduces duplication of effort, and supports more efficient management of multi-language clinical trials.

Clinical study protocols define the design, methodology, and procedures of a trial. Accurate translation of protocols ensures that investigators and study teams across regions are aligned on study requirements and execution. Consistent terminology between protocols and informed consent forms is essential for clarity and regulatory compliance.

Case Report Forms (CRFs) are used to collect and record clinical trial data. CRF translation requires precision and consistency, particularly for structured fields and repeated terminology. Aligning CRF translation with ICF translation helps maintain consistency between patient-facing content and data collection processes.

Patient recruitment materials include brochures, advertisements, and outreach content used to inform and enroll participants. These materials must be clear, culturally appropriate, and aligned with the language used in informed consent forms to ensure a consistent patient experience from initial outreach through enrollment.

Electronic Clinical Outcome Assessment (eCOA) and electronic Patient-Reported Outcomes (ePRO) content are used to capture patient data during a study. Translation of eCOA and ePRO content requires careful attention to clarity, usability, and consistency, often in conjunction with linguistic validation. Aligning these translations with ICF content helps ensure consistency in patient-facing language across all touchpoints.

Investigator brochures provide detailed information about the investigational product, including pharmacology, safety, and clinical data. Translating these documents accurately supports investigators and site staff in understanding the study and ensures alignment with both protocols and informed consent materials.

Regulatory submission documents include materials prepared for ethics committees, IRBs, and health authorities. These documents often require high levels of accuracy and consistency, as well as clear documentation of translation processes. Coordinating the translation of regulatory materials alongside ICFs helps streamline submissions and reduce the risk of inconsistencies or delays.

By translating these clinical trial documents together with informed consent forms, sponsors and CROs can maintain consistency across all study materials, improve operational efficiency, and support successful global trial execution.

Regulatory Considerations for ICF Translation

ICF translation sits at the center of regulatory review for global clinical trials. Informed consent forms are scrutinized by Institutional Review Boards (IRBs), ethics committees, and local health authorities to confirm that participants receive clear, accurate, and complete information in their own language. Strong informed consent translation practices help support approval timelines, reduce revision cycles, and demonstrate respect for patient rights across all study locations.

IRBs and ethics committees evaluate both the source and translated informed consent forms as part of the approval process. Their focus is on patient comprehension, completeness, and alignment with the study protocol.

Key expectations for ICF translation include:

  • Accurate and complete representation of the source content
  • Clear, patient-friendly language appropriate for the target population
  • Consistency between the ICF, protocol, and other clinical trial documents
  • Proper documentation of the translation and review process

High-quality informed consent translation helps reduce back-and-forth during review and supports smoother ethics approvals.

Most regulatory frameworks require that clinical trial consent forms be provided in the local language of each study population. This ensures that participants can fully understand the study before providing consent.

Local language requirements may include:

  • Use of region-specific language variants (for example, European Spanish vs. Latin American Spanish)
  • Adaptation for literacy levels and patient populations
  • Inclusion of locally required statements or formatting

ICF translation must account for these requirements while maintaining consistency with the original document.

Beyond language, each country may have unique regulatory expectations for informed consent forms. These can include differences in terminology, formatting, required disclosures, and approval workflows.

Examples of country-specific considerations:

  • Additional legal or privacy language required by local authorities
  • Differences in how risks, benefits, or compensation are presented
  • Formatting or structure requirements for submission
  • Variations in ethics committee review processes

Professional ICF translation supports these nuances by combining linguistic accuracy with local regulatory awareness.

Clinical trials often involve multiple protocol amendments, which require updates to informed consent forms across all languages. Maintaining version control is critical to ensure that all translated ICFs reflect the latest approved content.

Effective version management includes:

  • Tracking updates and changes across all language versions
  • Ensuring consistency between revised ICFs and other study documents
  • Coordinating updates across multiple countries and sites
  • Maintaining documentation for regulatory and audit purposes

A structured informed consent translation process helps manage amendments efficiently and reduces the risk of inconsistencies or delays.

By addressing these regulatory considerations, sponsors and CROs can support compliant, efficient clinical trial execution while maintaining high standards for patient communication across global studies.

Languages We Support for ICF Translation

Sesen provides ICF translation services in 150 languages, supporting global clinical trials across diverse regions and patient populations. Our informed consent translation workflows are designed to maintain accuracy, clarity, and consistency across all languages, helping sponsors and CROs manage multi-country studies with confidence.

We support both widely used and region-specific languages, with careful attention to local linguistic and regulatory requirements. This includes adapting informed consent forms to appropriate language variants and ensuring that clinical trial consent forms are clear and understandable for each target population.

Common Languages for Clinical Trial ICF Translation

Below are some of the most frequently requested languages for informed consent form translation in global clinical trials:

Support for both LATAM Spanish and European Spanish, with regional adaptations to reflect local terminology and regulatory expectations.

Including Canadian French for studies conducted in Quebec, with attention to local language standards and regulatory requirements.

Commonly required for clinical trials across Germany, Austria, and Switzerland, with precise handling of medical terminology.

Support for Simplified Chinese and Traditional Chinese, depending on the target market and regulatory requirements.

Accurate and culturally appropriate translation for clinical trials conducted in Japan, with a focus on clarity and formal language conventions.

High-quality translation for studies in South Korea, ensuring consistency with regulatory expectations and patient comprehension.

Including Polish, Czech, Hungarian, Romanian, Bulgarian, and other regional languages commonly required for multi-country clinical trials.

By supporting 150 languages for ICF translation, Sesen enables sponsors and CROs to scale clinical trials globally while maintaining consistent, high-quality informed consent translation across all study locations.

Why Choose Sesen

Why Sponsors and CROs Choose Sesen

Sesen supports sponsors and CROs with informed consent form (ICF) translation that is accurate, consistent, and aligned with the needs of global clinical trials. Our approach focuses on practical execution, clear communication, and reliable delivery across all study languages.

ICF translation is handled by professional native medical linguists with experience in clinical research and patient-facing content. This ensures that informed consent forms are translated with both medical accuracy and clarity for patient understanding.

We work extensively with clinical trial documents, including informed consent forms, protocols, and regulatory materials. This experience helps us maintain consistency across documents and align translations with study requirements and expectations.

Our process includes independent linguistic review and multiple quality checks to support accuracy and clarity. This structured workflow helps ensure that each informed consent translation reflects the original content while remaining clear and appropriate for the target audience.

We apply terminology management across all ICF translation projects, using glossaries and reference materials to maintain consistency across languages and documents. This is especially important for multi-country clinical trials where alignment is required across all study materials.

Sesen supports ICF translation for global studies involving multiple languages and regions. Our workflows are designed to scale efficiently while maintaining consistency, helping sponsors and CROs manage translation across all trial sites.

This combination of linguistic expertise, structured workflows, and scalable delivery allows sponsors and CROs to manage informed consent translation more effectively and support successful global clinical trial execution.

Turnaround Time for ICF Translation

Turnaround time for ICF translation depends on factors such as document length, number of languages, and project complexity. In most cases, informed consent forms can be translated efficiently while maintaining the level of accuracy and review required for clinical trial use.

For standard ICF translation projects, typical turnaround times are:

  • 2–3 business days for shorter informed consent forms
  • 3–5 business days for longer or more complex clinical trial consent forms

These timelines include translation and structured review workflows to support accuracy, consistency, and patient comprehension.

For time-sensitive studies, rush ICF translation services are available. Accelerated timelines can be supported through parallel workflows and dedicated linguistic resources.

Rush options may include:

  • 24–48 hour delivery for urgent informed consent translation needs
  • Priority handling for regulatory submissions or study startup timelines
  • Coordinated review processes to maintain quality under tighter deadlines

Rush timelines are evaluated based on document scope and language requirements to ensure realistic and reliable delivery.

For global clinical trials involving multiple languages, turnaround time includes coordination across all language versions to maintain consistency and alignment.

Typical considerations include:

  • Parallel translation and review across multiple languages
  • Centralized terminology management to ensure consistency
  • Alignment of delivery timelines across all study regions

Multi-language ICF translation projects are planned to balance speed and consistency, helping sponsors and CROs manage global study timelines more effectively.

Frequently Asked Questions (FAQ)

ICF translation refers to the translation of informed consent forms used in clinical trials. These documents explain study details, risks, benefits, and participant rights. Accurate informed consent translation ensures that patients in different countries can clearly understand the study before agreeing to participate.

Yes, in most cases ICF translations are required for Institutional Review Board (IRB) or ethics committee submission when a study involves non-English-speaking participants. Clinical trial consent forms must be provided in the local language to support patient understanding and meet regulatory expectations.

Yes, certified ICF translation can be provided when required for regulatory or institutional purposes. A certificate of translation confirms that the informed consent translation is accurate and complete to the best of our knowledge and can be included with submission materials.

ICF translation turnaround time depends on document length, complexity, and number of languages. Most informed consent forms can be completed within 2–5 business days, with faster turnaround available for urgent projects. Multi-language clinical trial consent forms may require additional coordination time.

Yes, we support ICF translation for multi-country clinical trials involving multiple languages. Our workflows are designed to maintain consistency across all language versions through terminology management and structured review processes.

Yes, we support ongoing updates and amendments to informed consent forms throughout the clinical trial lifecycle. This includes managing version control, updating translations across all languages, and ensuring consistency with revised protocols and study documents.

Related Services

Related Clinical Trial Translation Services

Informed consent form translation is one part of a broader clinical trial translation strategy. Sponsors and CROs often need to translate multiple types of study documentation alongside ICFs to support regulatory submissions, site activation, and ongoing trial operations. Sesen provides a full range of clinical translation services to help maintain consistency across all study materials.

For a complete overview of our capabilities, visit our clinical trial translation services page. This serves as the main hub covering translation support across all phases of global clinical research, including patient-facing, regulatory, and operational documents.

We translate a wide range of clinical study documents, including protocols, case report forms, and investigator materials. This ensures consistency between informed consent forms and the broader documentation used throughout the study.

Our GCP compliance translation services support documents that must align with Good Clinical Practice requirements. This includes materials reviewed by regulatory authorities and ethics committees, where accuracy and consistency are essential.

We provide translation for electronic clinical outcome assessments (eCOA) and electronic patient-reported outcomes (ePRO). Aligning these translations with ICF content helps ensure consistent patient-facing language across all study touchpoints.

By connecting informed consent translation with these related services, sponsors and CROs can manage global clinical trial translation more effectively while maintaining consistency, compliance, and operational efficiency across all study materials.

Get Reliable Informed Consent Form (ICF) Translations for Your Clinical Trials

Submit your ICF documents to receive accurate, compliant translations that support global clinical trial execution and patient understanding.

REQUEST A QUOTE REQUEST A QUOTE
CONTACT OUR TEAM CONTACT OUR TEAM